1. 2004
2. Published

   Pharmacoeconomic models that incorporate non-compliance

   Hughes, D. & Hughes, D. A., 1 Jul 2004.

   Research output: Contribution to conference › Paper

3. Published

   Pharmacoeconomics appraisals by the all Wales medicines strategy group

   Hughes, D. & Hughes, D. A., 1 Jul 2004.

   Research output: Contribution to conference › Paper

4. Published

   Cost-effectiveness analysis of HLA B*5701 genotyping in preventing abacavir hypersensitivity

   Hughes, D., Hughes, D. A., Vilar, F. J., Ward, C. C., Alfirevic, A., Park, B. K. & Pirmohamed, M., 1 Jun 2004, In: Pharmacogenetics. 14, 6, p. 335-342

   Research output: Contribution to journal › Article › peer-review

5. Published

   Patient compliance and persistence with prescribed medication: Measurement and health economic impact

   Hughes, D., Koncz, T., Hughes, D. A., Cleemput, I. & Annemans, L., 1 May 2004.

   Research output: Contribution to conference › Paper

6. Published

   Pharmacoeconomics in Wales: functions of the all Wales medicines strategy group

   Hughes, D. & Hughes, D. A., 1 Apr 2004.

   Research output: Contribution to conference › Paper

7. Published

   Pharmacoeconomics of pharmacogenetic testing: azathioprine

   Hughes, D., McAllister, R. & Hughes, D. A., 1 Apr 2004.

   Research output: Contribution to conference › Paper

8. Published

   Approaches to pharmacoeconomic analysis

   Hughes, D., Hughes, D. A., Walley, T. (ed.), Haycox, A. (ed.), Boland, A. (ed.) & Breckenridge, A. (ed.), 1 Jan 2004, Pharmacoeconomics. 2004 ed. Adis International, p. 101-126

   Research output: Chapter in Book/Report/Conference proceeding › Chapter

9. Published

   Clinical Pharmacology: Special safety considerations in drug development and pharmacovigilance.

   Hughes, D., Atuah, K. N., Hughes, D. A. & Pirmohamed, M., 1 Jan 2004, In: Drug Safety. 27, 8, p. 535-554

   Research output: Contribution to journal › Article › peer-review

10. Published

    Cost-effectiveness analysis of extended-release formulations of oxybutynin and tolterodine for the management of urge incontinence.

    Hughes, D., Hughes, D. A. & Dubois, D., 1 Jan 2004, In: Pharmacoeconomics. 22, 16, p. 1047-1059

    Research output: Contribution to journal › Article › peer-review

11. Published

    Internationalisation of cost-effectiveness model for on-demand use of proton pump inhibitors - Belgium.

    Hughes, D. & Hughes, D. A., 1 Jan 2004, 2004 ed. Unknown.

    Research output: Book/Report › Commissioned report